Gustavo C. Rodriguez

10.1k total citations
78 papers, 2.7k citations indexed

About

Gustavo C. Rodriguez is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Gustavo C. Rodriguez has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Reproductive Medicine, 21 papers in Oncology and 21 papers in Obstetrics and Gynecology. Recurrent topics in Gustavo C. Rodriguez's work include Ovarian cancer diagnosis and treatment (36 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Endometriosis Research and Treatment (12 papers). Gustavo C. Rodriguez is often cited by papers focused on Ovarian cancer diagnosis and treatment (36 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Endometriosis Research and Treatment (12 papers). Gustavo C. Rodriguez collaborates with scholars based in United States, Australia and Mexico. Gustavo C. Rodriguez's co-authors include Andrew Berchuck, Robert C. Bast, J. Hunn, Daniel L. Clarke‐Pearson, John T. Soper, Richard K. Dodge, Regina S. Whitaker, Angeles A. Alvarez, M. Sharon Stack and Timothy N. Young and has published in prestigious journals such as Cancer, Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

Gustavo C. Rodriguez

76 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gustavo C. Rodriguez United States 29 1.2k 781 733 607 498 78 2.7k
Elisabetta Kuhn Italy 28 1.2k 1.0× 886 1.1× 541 0.7× 594 1.0× 496 1.0× 75 2.5k
Debra A. Bell United States 33 2.0k 1.7× 668 0.9× 666 0.9× 868 1.4× 485 1.0× 80 3.3k
Yoshito Terai Japan 29 908 0.8× 1.1k 1.4× 697 1.0× 695 1.1× 451 0.9× 136 2.7k
Julie Irving United Kingdom 28 1.1k 0.9× 772 1.0× 388 0.5× 867 1.4× 293 0.6× 66 2.8k
Masanori Kaneuchi Japan 32 1.0k 0.9× 1.2k 1.5× 642 0.9× 1.4k 2.3× 692 1.4× 92 3.3k
John P. Geisler United States 27 926 0.8× 684 0.9× 563 0.8× 678 1.1× 299 0.6× 99 2.3k
Philippe Moerman Belgium 31 1.3k 1.1× 699 0.9× 772 1.1× 1.9k 3.1× 606 1.2× 125 3.6k
Deolinda Pereira Portugal 26 1.3k 1.1× 937 1.2× 1.3k 1.8× 266 0.4× 514 1.0× 86 2.8k
J. J. Kavanagh United States 32 1.2k 1.0× 859 1.1× 879 1.2× 728 1.2× 181 0.4× 95 3.0k
Marta A. Crispens United States 25 723 0.6× 568 0.7× 498 0.7× 447 0.7× 296 0.6× 62 1.8k

Countries citing papers authored by Gustavo C. Rodriguez

Since Specialization
Citations

This map shows the geographic impact of Gustavo C. Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo C. Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo C. Rodriguez more than expected).

Fields of papers citing papers by Gustavo C. Rodriguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo C. Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo C. Rodriguez. The network helps show where Gustavo C. Rodriguez may publish in the future.

Co-authorship network of co-authors of Gustavo C. Rodriguez

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo C. Rodriguez. A scholar is included among the top collaborators of Gustavo C. Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo C. Rodriguez. Gustavo C. Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutton, Linda, et al.. (2024). Patient engagement in designing and publishing research in prostate cancer: a scoping review. Future Oncology. 20(35). 2779–2790.
2.
Nelson, Omar L., Jane M. Turbov, Larry G. Thaete, et al.. (2024). Vitamin D Significantly Inhibits Carcinogenesis in the Mogp-TAg Mouse Model of Fallopian Tube Ovarian Cancer. Nutrients. 16(19). 3318–3318. 1 indexed citations
3.
Phuong, L., Austin Miller, Amanda Black, et al.. (2022). Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study. American Journal of Obstetrics and Gynecology. 227(1). 61.e1–61.e18. 3 indexed citations
4.
5.
6.
Rodriguez, Gustavo C., James Kauderer, J. Hunn, et al.. (2019). Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study. Cancer Prevention Research. 12(6). 401–412. 1 indexed citations
7.
Piedmonte, Marion, Paul K. J. Han, Richard P. Moser, et al.. (2017). Factors Associated With Deciding Between Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening Among High-Risk Women Enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group Study. Obstetrical & Gynecological Survey. 72(6). 336–337. 1 indexed citations
8.
9.
Hunn, J., Meaghan Tenney, Ana I. Tergas, et al.. (2015). Patterns and utility of routine surveillance in high grade endometrial cancer. Gynecologic Oncology. 137(3). 485–489. 23 indexed citations
10.
Lee, Laura R., Pang-ning Teng, Brian L. Hood, et al.. (2013). Progesterone Enhances Calcitriol Antitumor Activity by Upregulating Vitamin D Receptor Expression and Promoting Apoptosis in Endometrial Cancer Cells. Cancer Prevention Research. 6(7). 731–743. 42 indexed citations
11.
Rodriguez, Gustavo C., H. John Barnes, Kenneth E. Anderson, et al.. (2013). Evidence of a Chemopreventive Effect of Progestin Unrelated to Ovulation on Reproductive Tract Cancers in the Egg-laying Hen. Cancer Prevention Research. 6(12). 1283–1292. 13 indexed citations
12.
Bertrand, Kimberly A., Stalo Karageorgi, Edward L. Giovannucci, et al.. (2012). Prospective analysis of vitamin D and endometrial cancer risk. Annals of Oncology. 24(3). 687–692. 22 indexed citations
13.
Hunn, J. & Gustavo C. Rodriguez. (2012). Ovarian Cancer. Clinical Obstetrics & Gynecology. 55(1). 3–23. 234 indexed citations
14.
Barnes, H. John, Kenneth E. Anderson, James N. Petitte, et al.. (2011). Reduction of Ovarian and Oviductal Cancers in Calorie-Restricted Laying Chickens. Cancer Prevention Research. 4(4). 562–567. 18 indexed citations
15.
Hakim, Amy, H. John Barnes, Kenneth E. Anderson, et al.. (2009). Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu. Cancer Prevention Research. 2(2). 114–121. 65 indexed citations
16.
Secord, Angeles Alvarez, Laura J. Havrilesky, Michael E. Carney, et al.. (2007). Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. International Journal of Clinical Oncology. 12(1). 31–36. 24 indexed citations
17.
Berchuck, Andrew, Anthony C. Evans, John T. Soper, et al.. (1995). Postsurgical Surveillance of Patients with FIGO Stage I/II Endometrial Adenocarcinoma. Gynecologic Oncology. 59(1). 20–24. 86 indexed citations
18.
Rodriguez, Gustavo C., Claude L. Hughes, John T. Soper, et al.. (1994). Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia.. PubMed. 84(5). 794–7. 4 indexed citations
19.
Lukes, Andrea S., Matthew F. Kohler, Carl F. Pieper, et al.. (1994). Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Cancer. 73(9). 2380–2385. 134 indexed citations
20.
Xu, Fengji, Ruth Lupu, Gustavo C. Rodriguez, et al.. (1993). Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185. International Journal of Cancer. 53(3). 401–408. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Kuhn Breakdown of academic impact, for papers by Debra A. Bell Breakdown of academic impact, for papers by Yoshito Terai Breakdown of academic impact, for papers by Julie Irving Breakdown of academic impact, for papers by Masanori Kaneuchi Breakdown of academic impact, for papers by John P. Geisler Breakdown of academic impact, for papers by Philippe Moerman Breakdown of academic impact, for papers by Deolinda Pereira Breakdown of academic impact, for papers by J. J. Kavanagh Breakdown of academic impact, for papers by Marta A. Crispens
Rankless by CCL
2026